|
KLHL24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.954200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.376300E-02 |
| Normal-vs-Stage2 |
3.410600E-01 |
| Normal-vs-Stage3 |
3.73639999999842E-05 |
| Normal-vs-Stage4 |
4.27849999995455E-06 |
| Stage1-vs-Stage2 |
9.502000E-01 |
| Stage1-vs-Stage3 |
2.622100E-03 |
| Stage1-vs-Stage4 |
6.368300E-04 |
| Stage2-vs-Stage3 |
8.687900E-02 |
| Stage2-vs-Stage4 |
5.055600E-02 |
| Stage3-vs-Stage4 |
6.370200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.340860E-03 |
| Normal-vs-AfricanAmerican |
1.121290E-03 |
| Normal-vs-Asian |
6.993200E-01 |
| Caucasian-vs-AfricanAmerican |
3.006000E-01 |
| Caucasian-vs-Asian |
2.368400E-01 |
| AfricanAmerican-vs-Asian |
8.445500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.198900E-03 |
| Normal-vs-Female |
2.757000E-03 |
| Male-vs-Female |
7.437400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.584600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.334000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.55139999999232E-05 |
| Normal-vs-Age(81-100Yrs) |
5.84430000000191E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.876200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.530420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.636300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.262300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.700000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.099960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.718800E-01 |
| Normal-vs-Grade 2 |
5.943700E-02 |
| Normal-vs-Grade 3 |
8.393700E-04 |
| Normal-vs-Grade 4 |
2.12490000039978E-08 |
| Grade 1-vs-Grade 2 |
4.552600E-01 |
| Grade 1-vs-Grade 3 |
1.378150E-01 |
| Grade 1-vs-Grade 4 |
1.878280E-03 |
| Grade 2-vs-Grade 3 |
1.124760E-01 |
| Grade 2-vs-Grade 4 |
1.77570999999599E-05 |
| Grade 3-vs-Grade 4 |
2.395600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.755580E-01 |
| Normal-vs-ccB subtype |
3.197900E-02 |
| ccA subtype-vs-ccB subtype |
2.959600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.943300E-03 |
| Normal-vs-N1 |
1.984780E-03 |
| N0-vs-N1 |
1.643780E-01 |
|
|
